acrisorcin
{{Short description|Chemical compound}}
{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| image = Acrisorcin.png
| verifiedrevid = 477241233
| type = combo
| component1 = 9-Aminoacridine
| class1 = Antiseptic
| component2 = 4-Hexylresorcinol
| class2 = Antiseptic
| tradename =
| pregnancy_AU =
| pregnancy_US =
| pregnancy_category =
| legal_AU =
| legal_CA =
| legal_UK =
| legal_US =
| legal_status =
| routes_of_administration =
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 7527-91-5
| ATC_prefix = none
| ATC_suffix =
| PubChem = 24144
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 22568
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 2U918O4BEV
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02759
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201038
}}
Acrisorcin is a topical anti-infective typically used as a fungicide.{{Cite web|url=https://pubchem.ncbi.nlm.nih.gov/compound/24144|title=Acrisorcin| work = PubChem | publisher = U.S. National Library of Medicine |language=en|access-date=2019-03-26}} It is a combination of the active ingredients 9-aminoacridine and 4-hexylresorcinol.{{Cite web|url=https://echa.europa.eu/substance-information/-/substanceinfo/100.028.536|title=Acrisorcin - Substance Information | publisher = European Chemicals Agency (ECHA) |language=en-GB|access-date=2019-03-26}}
__TOC__
History
Acrisorcin was marketed as a cream under the trade name Akrinol, which has since been discontinued. It was developed at Indiana State University in 1961.{{cite journal | vauthors = | title = A new agent for the control of tinea versicolor. Acrisorcin (Akrinol) | journal = JAMA | volume = 196 | issue = 11 | pages = 1010 | date = June 1966 | pmid = 5952419 | doi = 10.1001/jama.1966.03100240144035 }}
Indications
Acrisorcin was used to combat pityriasis versicolor.